TriSalus Life Sciences, Inc. TLSI Revenue base redemption liability
Revenue base redemption liability at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept tlsi:RevenueBaseRedemptionLiability.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s revenue base redemption liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s revenue base redemption liability?
- TriSalus Life Sciences, Inc. (TLSI) reported revenue base redemption liability of $300K in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s revenue base redemption liability changed year-over-year?
- TriSalus Life Sciences, Inc.'s revenue base redemption liability decreased by 46.8% year-over-year, from $564K to $300K.
- What does revenue base redemption liability mean?
- This liability represents the obligation to redeem shares or financial instruments based on specific revenue-related performance triggers or contractual conditions. It is classified as non-current because the settlement is not expected within the upcoming fiscal year. This metric is critical for understanding potential future capital outflows tied to performance-based earn-outs or redemption rights.